Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • crackerjack.tej
    Junior Member
    • May 2013
    • 4

    #1

    Normalize coverage in Meth-Seq data

    Hello all,

    I am a total noob in analyzing NGS data, and I would really appreciate if I can get help with my prob. Also, kindly excuse me if I'm using the wrong terminology to describe something.

    My experiment:
    Analysis of differences in DNA methylation across genome. Methylated DNA was pulled down using 5-methyl C antibody, and sequencing was performed using SOLiD. 4 samples were processed, as follows:

    1. Control, Initial Timepoint
    2. Test, Initial Timepoint
    3. Control, Final Timepoint
    4. Test, Final Timepoint

    All raw data was analyzed and filtered by the people who helped me operate the machine, and they finally gave me .bam files, which I opened using IGV genome browser.

    My problem:
    The fold coverage for the third sample is relatively low, while all the others are good. Because of this, when I see regions where the number of hits are different between samples, I don't know if it's because of the differences in fold coverage or they are genuinely differently methylated. In other words, I have no control over the number of false positives I'm detecting. This was more apparent when I tried to manually validate the results by bisulfite sequencing, as I couldn't see differences in methylation even at regions that showed largest difference in SOLiD data.

    My question:
    Firstly, what is the way to normalize the coverage for all samples? Is there a way I can find out a multiplication factor which I can use to multiply the hits I get in sample 3 to normalize the coverage? In addition, what is the flowchart or pipeline for me to analyze this data automatically - normalization of coverage, detection of false positives, and generation of a list of genuine targets. I can say I have a bit of bioinformatics and programming knowledge so I'm fairly open to using scripts or any other similar tactics.

    I'm sorry for rambling on so much. I will appreciate any kind of help that I can get with this problem.

    Thank you all,

    TEJ

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...